SCHEMBL3362035

SCHEMBL3362035

O=P(O)(O)CC=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10584139 0.75
SCHEMBL1516769 0.72 KDM4E (0.44)
SCHEMBL1516784 0.72 KDM4E (0.44)
SCHEMBL261595 0.69
SCHEMBL28100631 0.67
SCHEMBL28487733 0.67
SCHEMBL1303156 0.67
SCHEMBL11080729 0.67
SCHEMBL9790071 0.67
SCHEMBL30383 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180264080-A1 TOPICAL APPLICATIONS OF Kv1.3 CHANNEL BLOCKING PEPTIDES TO TREAT SKIN INFLAMMATION KINETA ONE, LLC (US) 2018-09-20 US disclosed
US-9937230-B2 Ophthalmic uses of toxin-based therapeutic peptides and pharmaceutical compositions thereof KINETA ONE, LLC (US) 2018-04-10 US disclosed
US-20160338967-A1 SUSTAINED RELEASE DEPOT FORMULATIONS OF THERAPEUTIC PROTEINS, AND USES THEREOF KINETA ONE, LLC (US) 2016-11-24 US disclosed
EP-3086779-A2 SUSTAINED RELEASE DEPOT FORMULATIONS OF THERAPEUTIC PROTEINS, AND USES THEREOF Kineta One, LLC (US) 2016-11-02 EP disclosed
WO-2016112208-A2 TOPICAL APPLICATIONS OF KV1.3 CHANNEL BLOCKING PEPTIDES TO TREAT SKIN INFLAMMATION KINETA ONE, LLP (US) 2016-07-14 WO disclosed
US-20160151457-A1 OPHTHALMIC USES OF TOXIN-BASED THERAPEUTIC PEPTIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF KINETA ONE, LLC (US) 2016-06-02 US disclosed
EP-3024472-A2 OPHTHALMIC USES OF TOXIN-BASED THERAPEUTIC PEPTIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF Kineta One, LLC (US) 2016-06-01 EP disclosed
WO-2015100370-A2 SUSTAINED RELEASE DEPOT FORMULATIONS OF THERAPEUTIC PROTEINS, AND USES THEREOF KINETA ONE, LLC (US) 2015-07-02 WO disclosed
WO-2015013330-A2 OPHTHALMIC USES OF TOXIN-BASED THERAPEUTIC PEPTIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF KINETA ONE, LLC (US) 2015-01-29 WO disclosed
US-7649015-B2 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds GILEAD SCIENCES, INC. (US) 2010-01-19 US disclosed
EP-1509537-A2 CELLULAR ACCUMULATION OF PHOSPHONATE ANALOGS OF HIV PROTEASE INHIBITOR COMPOUNDS AND THE COMPOUNDS AS SUCH GILEAD SCIENCES, INC. (US) 2005-03-02 EP disclosed
WO-2003090690-A2 CELLULAR ACCUMULATION OF PHOSPHONATE ANALOGS OF HIV PROTEASE INHIBITOR COMPOUNDS AND THE COMPOUNDS AS SUCH GILEAD SCIENCES, INC. (US) 2003-11-06 WO disclosed
EP-0676406-A3 Process for preparing thiocarbonylmethanephosphonic acid diesters. HOECHST AG (DE) 1996-08-21 EP disclosed
EP-0676407-A3 Process for preparing thiocarbonylmethanephosphonic acid diesters. HOECHST AG (DE) 1996-08-21 EP disclosed
EP-0676406-A2 Process for preparing thiocarbonylmethanephosphonic acid diesters HOECHST AKTIENGESELLSCHAFT (DE) 1995-10-11 EP disclosed
EP-0676406-A2 Process for preparing thiocarbonylmethanephosphonic acid diesters HOECHST AKTIENGESELLSCHAFT (DE) 1995-10-11 EP disclosed
EP-0676407-A2 Process for preparing thiocarbonylmethanephosphonic acid diesters HOECHST AKTIENGESELLSCHAFT (DE) 1995-10-11 EP disclosed
EP-0676407-A2 Process for preparing thiocarbonylmethanephosphonic acid diesters HOECHST AKTIENGESELLSCHAFT (DE) 1995-10-11 EP disclosed
WO-1995011911-A1 BINDING COMPETENT OLIGOMERS CONTAINING UNSATURATED 3',5' AND 2',5' LINKAGES GLAXO WELLCOME INC. (US) 1995-05-04 WO disclosed
US-5098897-A O-methyl thionoethanephosphonate derivatives BAYER AKTIENGESELLSCHAFT (DE) 1992-03-24 US disclosed